David Shaw’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.9M Hold
1,580,345
0.01% 1513
2026
Q1
$2.75M Buy
1,580,345
+125,450
+9% +$243K ﹤0.01% 2672
2025
Q4
$1.37M Hold
1,454,895
﹤0.01% 3333
2025
Q3
$436K Hold
1,454,895
﹤0.01% 3928
2025
Q2
$393K Hold
1,454,895
﹤0.01% 3744
2025
Q1
$55.3K Hold
1,454,895
﹤0.01% 4058
2024
Q4
$235K Buy
1,454,895
+107,456
+8% +$31.8K ﹤0.01% 4007
2024
Q3
$189K Hold
1,347,439
﹤0.01% 4174
2024
Q2
$96.1K Hold
1,347,439
﹤0.01% 4170
2024
Q1
$216K Hold
1,347,439
﹤0.01% 3894
2023
Q4
$445K Buy
+1,347,439
New +$602K ﹤0.01% 3566

Other funds holding RVMDW

David Shaw's RVMDW Position: Q2 2026 in Review

David Shaw held its Revolution Medicines Inc Warrant (RVMDW) position steady in Q2 2026 at 1,580,345 shares worth $14.9M. The position accounts for 0.01% of the portfolio, ranked #1513.

David Shaw first reported a position in RVMDW in Q4 2023 and has held it in 11 quarters since. 22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

  • David Shaw held 1,580,345 shares of Revolution Medicines Inc Warrant worth $14.9M as of Q2 2026.
  • David Shaw left its Revolution Medicines Inc Warrant share count unchanged in Q2 2026.
  • Revolution Medicines Inc Warrant made up 0.01% of David Shaw's portfolio in Q2 2026, its #1513 holding.
  • David Shaw first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 11 quarters since.
  • 22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.